Lots of good news for long suffering patients and SH in the announcement today.
My favourite bit (apart from the huge +ve of having Dr Stamler on board):
"Dr. Stamler’s appointment follows a detailed review of the pharmaceutical assets and strategy at Prana over the last 6 months..."
In other words, he's looked under the bonnet, figured it's a goer and decided it would be an excellent career move.
Not so favourite bit:
"In parallel, the company is exploring new options for PBT2 and building its pipeline..."
Good to see PBT2 is still on the table but I am hoping that my read-between-the-lines that suggests Prana needs new candidates to get back on track and PBT2 is all but abandoned in the clinic, is wrong.
- Forums
- ASX - By Stock
- Ann: David Stamler appointed as CMO to lead Clinical Development
Lots of good news for long suffering patients and SH in the...
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
-0.001(11.1%) |
Mkt cap ! $20.98M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $14.55K | 3.241M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
62 | 71906262 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 32338803 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
59 | 71406262 | 0.004 |
55 | 50902564 | 0.003 |
16 | 38864402 | 0.002 |
14 | 93470101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 32288803 | 24 |
0.006 | 34096588 | 15 |
0.007 | 16220649 | 14 |
0.008 | 14855575 | 14 |
0.009 | 8000000 | 6 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online